Yun-Long Zhang Selected Research

Cardiac Edema

1/2022	Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms.
1/2021	VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Long Zhang Research Topics

Disease

17	Fibrosis (Cirrhosis) 02/2022 - 01/2014
14	Inflammation (Inflammations) 02/2022 - 03/2016
14	Hypertension (High Blood Pressure) 02/2022 - 03/2016
13	Hypertrophy 01/2022 - 02/2015
12	Cardiomegaly (Heart Hypertrophy) 01/2021 - 02/2015
8	Atrial Fibrillation 01/2022 - 01/2018
7	Heart Diseases (Heart Disease) 02/2022 - 02/2015
6	Heart Failure 01/2022 - 01/2015
4	Atrial Remodeling 01/2022 - 01/2019
4	Neoplasms (Cancer) 09/2021 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2022 - 02/2015
2	Reperfusion Injury 01/2022 - 12/2019
2	Cardiac Edema 01/2022 - 01/2021
2	Epilepsy (Aura) 02/2021 - 01/2019
2	Hypertensive Retinopathy 01/2020 - 01/2018
2	Myocardial Infarction 12/2019 - 03/2018
2	Vascular System Injuries 01/2018 - 03/2016
1	Edema (Dropsy) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Seizures (Absence Seizure) 02/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020
1	Vascular Remodeling 01/2020
1	Atherosclerosis 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 06/2019
1	Pulmonary Hypertension 01/2019
1	Shock 03/2018

Drug/Important Bio-Agent (IBA)

16	Angiotensin IIIBA 02/2022 - 01/2014
6	Superoxides (Superoxide)IBA 02/2022 - 01/2018
5	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022 - 02/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2015
4	CytokinesIBA 02/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
3	Connexin 43 (Connexin43)IBA 01/2021 - 01/2018
3	Chemokine ReceptorsIBA 10/2020 - 01/2018
3	LDN 57444IBA 10/2020 - 01/2020
3	SB 225002IBA 10/2020 - 12/2019
3	VO-OHpicIBA 01/2020 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2020 - 01/2018
3	Gallic AcidIBA 01/2020 - 01/2019
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 03/2016
2	AngiotensinsIBA 01/2022 - 03/2016
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 01/2021
2	LipidsIBA 10/2021 - 01/2014
2	Deubiquitinating EnzymesIBA 10/2020 - 01/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2019
2	TensinsIBA 01/2020 - 01/2018
2	Chymotrypsin FDA Link 01/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 12/2019
2	Neutralizing AntibodiesIBA 01/2020 - 01/2018
2	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2019 - 01/2018
2	ResveratrolIBA 12/2019 - 01/2019
2	SaltsIBA 12/2019 - 01/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 03/2016
2	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018 - 01/2018
1	Therapeutic UsesIBA 02/2022
1	ProteomeIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	epoxomicinIBA 01/2022
1	cadherin 5IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	4-phenylbutylamineIBA 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2021
1	afliberceptIBA 09/2021
1	gamma-Aminobutyric Acid (GABA)IBA 02/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	CalcineurinIBA 01/2021
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 10/2020
1	PR-957IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 12/2019
1	Desoxycorticosterone (Deoxycorticosterone)IBA 12/2019
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	CXC ChemokinesIBA 12/2019
1	AntibodiesIBA 06/2019
1	Rituximab (Mabthera)FDA Link 06/2019
1	HexokinaseIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Galactosylceramides (Galactocerebrosides)IBA 01/2019
1	bromopyruvateIBA 01/2019
1	4(4- (5- nitro- furan- 2- ylmethylene)- 3,5- dioxo- pyrazolidin- 1- yl)- benzoic acid ethyl esterIBA 10/2018

Therapy/Procedure

4	Therapeutics 02/2021 - 03/2018
2	Ketogenic Diet 02/2021 - 01/2019
1	Ligation 01/2022
1	Punctures 01/2022
1	Counterpulsation (External Counterpulsation) 03/2018